What Remexian Pharma does

Remexian Pharma GmbH is a Ludwigsfelde, Germany-based pharmaceutical wholesaler founded in 2018 that specializes in the importation and wholesale distribution of medical cannabis to German pharmacies. The company sources products from 19 countries globally with a focus on EU-produced cannabis, operating under EU-Good Manufacturing Practice (GMP) and EU-Good Distribution Practice (GDP) standards. Remexian holds wholesale authorization per §52a AMG, narcotics authorization, and manufacturer authorization per §13 AMG, and has secured exclusive German distribution partnerships with six Canadian medical cannabis brands (Tribal, Highly Dutch Organic, Weed Me, The Loud Plug, Joi Botanicals, and Castle Rock Farms). The company has captured approximately 14% of Germany's medical cannabis market as of June 2026.

The business model is B2B wholesale distribution: Remexian imports medical cannabis from licensed producers and sells to pharmacies and licensed pharmaceutical wholesalers in Germany under standard 14-day payment terms. Revenue is generated on the margin between import cost and wholesale price. The company is majority-owned (51%) by High Tide Inc. (NASDAQ: HITI), a Canadian cannabis retail company that acquired its controlling stake for €26.4 million in September 2025, implying an enterprise value of approximately €51.8 million. Since acquisition, Remexian has generated $25M in Q1 FY2026 and a record $31.6M in Q2 FY2026 (with 27% gross margins). Operational management is led by Managing Directors Stefan Adomeit and Francesco Baganz, with a team of approximately 10 employees as of late 2024.

Remexian participates in major industry events such as Mary Jane Berlin 2026 and is positioned within Germany's regulated medical cannabis framework as a key import and distribution intermediary. The company's competitive position is anchored by regulatory licensing, exclusive brand partnerships, and an EU-GMP/GDP-compliant cold chain, with strategic integration into High Tide's broader European expansion strategy — including High Tide's first international Canna Cabana retail store opened in Berlin-Mitte in December 2025.

Name

Remexian Pharma

Legal name

Remexian Pharma GmbH

Website

https://remexian.com

Company type

Private

Founded year

2018

Operating status

Operating

Headcount range

1–10 employees

Short description

Remexian Pharma GmbH is a German pharmaceutical wholesaler that imports and distributes medical cannabis to pharmacies across Germany, holding 14% market share and exclusive distribution rights to six Canadian cannabis brands. Majority-owned by High Tide Inc. since September 2025.

Ownership category

akta.pro rank

Product category

Pharmaceutical Wholesale Distribution

NAICS

Drugs and Druggists' Sundries Merchant Wholesalers (424210), Medicinal and Botanical Manufacturing (325411)

SIC

Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122), Medicinal Chemicals & Botanical Products (2833)

akta.pro primary industry

Cannabis Wholesale Distribution (Flower, Extracts, Edibles) (CRAOAIAF)

Keywords

• Medical cannabis distribution
• Pharmaceutical wholesale
• Cannabis import services
• EU-GMP compliant supply chain
• Medical cannabis pharmacy supply

Headquarters

HQ city

Ludwigsfelde

HQ country

Germany

HQ region

Europe

Offices2 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Supply Chain, Operations, Personnel, Marketing or Sales, Technology or R&D

Revenue model

1. Medical Cannabis Distribution: Remexian Pharma generates revenue through the importation and wholesale distribution of medical cannabis products to pharmacies across Germany. The company imports products from licensed producers (primarily from Canada and EU countries) and distributes them to German pharmacies, generating revenue from the margin between import/purchase price and wholesale sale price to pharmacies.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels1 record

Core offering

Remexian Pharma GmbH imports and wholesale-distributes medical cannabis to pharmacies across Germany. The company sources products from 19 countries, with particular emphasis on EU-produced cannabis, and holds exclusive German distribution rights for six Canadian medical cannabis brands. It operates under EU-GMP and EU-GDP pharmaceutical quality standards, ensuring consistent availability and quality from manufacturing through delivery to pharmacies.

Product overview

Remexian Pharma operates as a pharmaceutical company specializing in medical cannabis import and wholesale distribution. The company operates as a unified import-distribution platform, sourcing medical cannabis from 19 countries (with emphasis on EU-produced cannabis) and distributing to German pharmacies. Their portfolio includes exclusive distribution partnerships with six Canadian medical cannabis brands (Tribal, Highly Dutch Organic, Weed Me, The Loud Plug, Joi Botanicals, and Castle Rock Farms). The company holds approximately 14% of Germany's medical cannabis market and operates under EU GMP and GDP pharmaceutical standards.

Differentiator

Problem solved

Functional benefit

Products and services

• Medical Cannabis Import and Wholesale Distribution Licensed import of medical cannabis from 19 countries and wholesale distribution of standardized medical cannabis products to pharmacies throughout Germany. Operates under EU-GMP and EU-GDP pharmaceutical quality standards across the full supply chain.

Quantifiable outcome

• Record Q2 FY2026 revenue of $31.6 million with 27% gross margins, more than double the prior quarter

Named customers1 record

Segments1 record

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

Six partnerships are on record, tiered core.

• TribalcoreChannel Partner/ Reseller/ Distributor · 11 June 2026Remexian Pharma holds an exclusive distribution partnership with Tribal, a Canadian medical cannabis brand. Tribal's products are introduced to German patients, pharmacies, and healthcare professionals through Remexian's growing distribution network in Germany.
• Highly Dutch OrganiccoreChannel Partner/ Reseller/ Distributor · 11 June 2026Remexian Pharma holds an exclusive distribution partnership with Highly Dutch Organic, a Canadian medical cannabis brand. The brand's products are distributed exclusively through Remexian's pharmacy network in Germany.
• Weed MecoreChannel Partner/ Reseller/ Distributor · 11 June 2026Remexian Pharma holds an exclusive distribution partnership with Weed Me, a Canadian medical cannabis brand. The partnership brings Weed Me's products to the German medical cannabis market via Remexian's distribution infrastructure.
• The Loud PlugcoreChannel Partner/ Reseller/ Distributor · 11 June 2026Remexian Pharma holds an exclusive distribution partnership with The Loud Plug, a Canadian medical cannabis brand, distributing its products exclusively to German pharmacies and patients.
• Joi BotanicalscoreChannel Partner/ Reseller/ Distributor · 11 June 2026Remexian Pharma holds an exclusive distribution partnership with Joi Botanicals, a Canadian medical cannabis brand, bringing its differentiated product portfolio to the German medical cannabis ecosystem.
• Castle Rock FarmscoreChannel Partner/ Reseller/ Distributor · 11 June 2026Remexian Pharma holds an exclusive distribution partnership with Castle Rock Farms, a Canadian medical cannabis brand, with products distributed through Remexian's growing German pharmacy network.

Scale indicators5 records

Recent moves6 records

Expansion highlights5 records

Market position

Competitive moat3 records

Key risks6 records

Key highlights7 records

Customer concentration

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Remexian Pharma